The endoscopic light imaging system helps resolve lesions without dyes or contrast agents by helping to see vessel networks. The technology is indicated for assessing non-muscle-invasive bladder cancer in patients, but it is not intended to supplant histopathological sampling for the definitive diagnosis.
More articles on gastroenterology and endoscopy:
Adopting the updated GI procedure quality metrics & what this means for practice
Making the most of 2015: New Year’s resolutions in GI
10 most-read GI/endoscopy stories of 2014
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.